Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study

Abstract Background An epidemiological link between Parkinson's disease (PD) and cutaneous malignant melanoma (CMM) has been widely reported. The role of CMM risk factors in this association is unclear. Objectives To compare rates of risk factors for skin tumours, specifically actinic keratosis...

Full description

Saved in:
Bibliographic Details
Main Authors: Esther Azizi, Hana Feuerman, Idit Peleg, Felix Pavlotsky, Zvi Segal, Bernice Oberman, Nirit Lev, Emmilia Hodak, Ruth Djaldetti, Sharon Hassin‐Baer, Rivka Inzelberg
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Skin Health and Disease
Online Access:https://doi.org/10.1002/ski2.464
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846146223897051136
author Esther Azizi
Hana Feuerman
Idit Peleg
Felix Pavlotsky
Zvi Segal
Bernice Oberman
Nirit Lev
Emmilia Hodak
Ruth Djaldetti
Sharon Hassin‐Baer
Rivka Inzelberg
author_facet Esther Azizi
Hana Feuerman
Idit Peleg
Felix Pavlotsky
Zvi Segal
Bernice Oberman
Nirit Lev
Emmilia Hodak
Ruth Djaldetti
Sharon Hassin‐Baer
Rivka Inzelberg
author_sort Esther Azizi
collection DOAJ
description Abstract Background An epidemiological link between Parkinson's disease (PD) and cutaneous malignant melanoma (CMM) has been widely reported. The role of CMM risk factors in this association is unclear. Objectives To compare rates of risk factors for skin tumours, specifically actinic keratosis (AK), non‐melanoma skin cancer (NMSC) and CMM, between persons with and without PD. Methods In this cross‐sectional observational study, patients attending tertiary PD clinics and community controls were interviewed for background/medical data and underwent dermatological examination. Logistic regression models assessed risk factors for skin tumours and their interactions with PD status. Results Included were 141 persons with PD and 155 controls; mean age 71.7 and 72.6 years, respectively. In both groups, the majority were males of Ashkenazi origin. Altogether, AK, basal cell carcinoma, squamous cell carcinoma and CMM were recorded in 76 (53.9%) persons with PD and 92 (59.3%) controls (NS). CMM prevalence predominated in PD patients. In the PD group, prolonged sun exposure (p = 0.007), freckles (p < 0.001) and solar lentigines (p = 0.008) were associated with skin tumours. In the control group, dysplastic atypical moles were negatively associated with skin tumours (p = 0.017). Logistic regression of the whole cohort showed that older age (p < 0.001), fair complexion (p = 0.04) and prolonged sun exposure (p = 0.01) were associated with skin tumours, but PD status was not independently associated, and no interactions were found between PD status and CMM risk factors. Conclusions Periodic dermatological screening of PD populations is mandatory, especially for carriers of major phenotypic risk factors or presenting with AK, NMSC or CMM.
format Article
id doaj-art-5b90d9e514e94df089487dfe7c9b463e
institution Kabale University
issn 2690-442X
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Skin Health and Disease
spelling doaj-art-5b90d9e514e94df089487dfe7c9b463e2024-12-02T04:03:51ZengWileySkin Health and Disease2690-442X2024-12-0146n/an/a10.1002/ski2.464Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional studyEsther Azizi0Hana Feuerman1Idit Peleg2Felix Pavlotsky3Zvi Segal4Bernice Oberman5Nirit Lev6Emmilia Hodak7Ruth Djaldetti8Sharon Hassin‐Baer9Rivka Inzelberg10Department of Dermatology Chaim Sheba Medical Center Tel Hashomer IsraelFaculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelFaculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelDepartment of Dermatology Chaim Sheba Medical Center Tel Hashomer IsraelDepartment of Dermatology Chaim Sheba Medical Center Tel Hashomer IsraelFaculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelFaculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelFaculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelFaculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelFaculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelDepartment of Neurology and Neurosurgery Sagol School of Neuroscience The Faculty of Medicine & Health Sciences Tel Aviv University Tel Aviv IsraelAbstract Background An epidemiological link between Parkinson's disease (PD) and cutaneous malignant melanoma (CMM) has been widely reported. The role of CMM risk factors in this association is unclear. Objectives To compare rates of risk factors for skin tumours, specifically actinic keratosis (AK), non‐melanoma skin cancer (NMSC) and CMM, between persons with and without PD. Methods In this cross‐sectional observational study, patients attending tertiary PD clinics and community controls were interviewed for background/medical data and underwent dermatological examination. Logistic regression models assessed risk factors for skin tumours and their interactions with PD status. Results Included were 141 persons with PD and 155 controls; mean age 71.7 and 72.6 years, respectively. In both groups, the majority were males of Ashkenazi origin. Altogether, AK, basal cell carcinoma, squamous cell carcinoma and CMM were recorded in 76 (53.9%) persons with PD and 92 (59.3%) controls (NS). CMM prevalence predominated in PD patients. In the PD group, prolonged sun exposure (p = 0.007), freckles (p < 0.001) and solar lentigines (p = 0.008) were associated with skin tumours. In the control group, dysplastic atypical moles were negatively associated with skin tumours (p = 0.017). Logistic regression of the whole cohort showed that older age (p < 0.001), fair complexion (p = 0.04) and prolonged sun exposure (p = 0.01) were associated with skin tumours, but PD status was not independently associated, and no interactions were found between PD status and CMM risk factors. Conclusions Periodic dermatological screening of PD populations is mandatory, especially for carriers of major phenotypic risk factors or presenting with AK, NMSC or CMM.https://doi.org/10.1002/ski2.464
spellingShingle Esther Azizi
Hana Feuerman
Idit Peleg
Felix Pavlotsky
Zvi Segal
Bernice Oberman
Nirit Lev
Emmilia Hodak
Ruth Djaldetti
Sharon Hassin‐Baer
Rivka Inzelberg
Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study
Skin Health and Disease
title Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study
title_full Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study
title_fullStr Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study
title_full_unstemmed Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study
title_short Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study
title_sort risk factors for actinic keratosis non melanoma skin cancer and cutaneous malignant melanoma in persons with and without parkinson s disease a cross sectional study
url https://doi.org/10.1002/ski2.464
work_keys_str_mv AT estherazizi riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT hanafeuerman riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT iditpeleg riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT felixpavlotsky riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT zvisegal riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT berniceoberman riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT niritlev riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT emmiliahodak riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT ruthdjaldetti riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT sharonhassinbaer riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy
AT rivkainzelberg riskfactorsforactinickeratosisnonmelanomaskincancerandcutaneousmalignantmelanomainpersonswithandwithoutparkinsonsdiseaseacrosssectionalstudy